Innate Pharma
IPHA
#9113
Rank
ยฃ97.79 M
Marketcap
ยฃ1.04
Share price
2.92%
Change (1 day)
-31.09%
Change (1 year)

Market capitalization of Innate Pharma (IPHA)

Market cap: ยฃ97.79 Million

As of April 2026 Innate Pharma has a market cap of ยฃ97.79 Million. This makes Innate Pharma the world's 9113th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Innate Pharma from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ97.79 M-21.15%
2025ยฃ0.12 B-10.94%
2024ยฃ0.13 B-22.95%
2023ยฃ0.18 B-26.92%
2022ยฃ0.24 B-16.67%
2021ยฃ0.29 B20.27%
2020ยฃ0.24 B-38.51%
2019ยฃ0.40 B-6.46%
2018ยฃ0.42 B78.01%
2017ยฃ0.24 B-64.27%
2016ยฃ0.67 B25.46%
2015ยฃ0.53 B64.57%
2014ยฃ0.32 B72.12%
2013ยฃ0.18 B181.74%
2012ยฃ67.35 M103.49%
2011ยฃ33.1 M-12.56%
2010ยฃ37.85 M-52.82%
2009ยฃ80.23 M136.22%
2008ยฃ33.96 M-26.55%
2007ยฃ46.24 M-36.57%
2006ยฃ72.91 M

End of Day market cap according to different sources

On Apr 24th, 2026 the market cap of Innate Pharma was reported to be:

ยฃ93.59 Million
by Nasdaq info icon info icon
ยฃ97.79 Million
by CompaniesMarketCap info icon info icon